That said, in one study of people with moderate to severe COPD, there was no difference in measured outcomes (like COPD symptoms, use of relief medications, or change in FEV1 after using an inhaler).

AstraZeneca still trades at a premium valuation, but several factors limit its upside potential in the next visible period. There are three negative takeaways from China. IRA could also ...

UK-based pharmaceutical giant AstraZeneca has announced plans to restructure its biopharma unit to concentrate on next-generation therapeutics. “In the Biopharmaceutical Business Unit, we are now ...

IT worker can continue legal battle against pharmaceutical giant after judge rules that impact of skin condition makes him a disabled person An IT worker has won a legal battle to sue AstraZeneca ...

AstraZeneca India has laid off over 125 employees in its biopharmaceutical business unit, including senior managers and sales executives. The job cuts are part of a strategic restructuring due to loss ...

The electrostatic charge on a standard spacer can be decreased by priming with a puff from the inhaler (not cost-efficient), using an electrostatic coating, or washing in detergent without rinsing.

ABSTRACT: The assessment of extractable and leachables (E&L) has become a cornerstone of pharmaceutical product safety, yet no unified global standards currently exist to quantify or report E&L from ...

LONDON, Dec 24 (Reuters) - AstraZeneca (AZN.L), opens new tab has voluntarily withdrawn its marketing authorisation application with the EU's medicines regulator for its experimental precision ...

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of AstraZeneca PLC (NASDAQ ...

The early unlock gives you another drug-mixing slot, which can be a real game changer. When you look at your medical inhaler in the inventory, you’ll notice multiple slots. The first one will likely ...

The news followed an investigation by POLITICO’s E&E News into climate-friendly inhalers and how drug giants are developing them to undermine competition. The pharmaceutical giant AstraZeneca ...